Structure of aspartoacylase, the brain enzyme impaired in Canavan disease
about
sameAs
Expression and localization of myosin-1d in the developing nervous systemAspartoacylase-lacZ knockin mice: an engineered model of Canavan diseaseExamination of the Mechanism of Human Brain Aspartoacylase through the Binding of an Intermediate Analogue † , ‡Structures of aminoacylase 3 in complex with acetylated substratesCarboxypeptidase O is a glycosylphosphatidylinositol-anchored intestinal peptidase with acidic amino acid specificityMutational analysis of aspartoacylase: implications for Canavan diseaseTwo patients with Canavan disease and structural modeling of a novel mutation.Linking mechanistic and behavioral responses to sublethal esfenvalerate exposure in the endangered delta smelt; Hypomesus transpacificus (Fam. Osmeridae)Carboxypeptidases in disease: insights from peptidomic studies.Long-term follow-up after gene therapy for canavan disease.Modification of aspartoacylase for potential use in enzyme replacement therapy for the treatment of Canavan diseaseStructure and computational analysis of a novel protein with metallopeptidase-like and circularly permuted winged-helix-turn-helix domains reveals a possible role in modified polysaccharide biosynthesisThe impact of structural biology on neurobiology.A structural and functional analysis of Nna1 in Purkinje cell degeneration (pcd) mice.N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cellsMouse aminoacylase 3: a metalloenzyme activated by cobalt and nickelThe molecular mechanisms affecting N-acetylaspartate homeostasis following experimental graded traumatic brain injury.A thematic review of scientific and family interests in Canavan Disease: where are the developmentalists?Genome-wide gene expression profiling and mutation analysis of Saudi patients with Canavan disease.Clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity.Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme.Stimulation-induced transient changes in neuronal activity, blood flow and N-acetylaspartate content in rat prefrontal cortex: a chemogenetic fMRS-BOLD study.Structural modeling of p.V31F variant in the aspartoacylase gene.ASPA deacetylates NAA to acetate and L-aspartateNovel mutation in an Egyptian patient with infantile Canavan disease.
P2860
Q24303720-91B5F4BB-1205-4C73-867E-D031EA538D79Q27339223-BE8AD540-D4B3-4963-BEF4-B7FF29668049Q27649917-335A17EB-D800-4CAE-A752-AD000CB4FE4DQ27664897-A9226BFA-88E4-4C19-99F0-AF17C2065B89Q28115334-59C80AD4-0D9F-46AB-B886-632E91FA4582Q28295349-96C7A5C5-F82B-4042-97E1-78733AC504ACQ30391885-BB60A6BE-B139-47EF-A905-27745447E0F3Q33518044-23B9E2B7-B300-4DA7-9ED0-D028960793E6Q33772669-E47B1E25-FBCB-4793-A778-88AB258A4CB6Q34318553-6A3D83DB-D06D-4ED0-A5E5-804B4FD1D499Q34500635-21469668-0E4E-4DFE-81E9-DCF7634D6C21Q35124725-85A04869-2C97-4789-80E8-572835AA8702Q35578647-77133EA1-0CAE-49B4-ADC0-9642F83F88BBQ36329799-E4BFEE9A-0290-4F32-8E81-AF6C2553C233Q37151094-0AA90D6D-C0FE-427F-8245-994DCDA609DCQ37328347-311ADD46-5B28-420B-B891-7EFDCFB7BF77Q37666248-2854A151-A2C1-4705-862F-8ADC2600F7DAQ38016942-82DD9D83-804B-4D49-85BC-A631ED94EA47Q38359413-287F37EE-1809-4E29-AB18-D5820B2AF277Q39013120-834FEF71-8A9B-4320-8C51-F1A8997D4D8BQ47844285-3E776B3C-D96C-4E10-AD2D-16B974238D82Q48489598-9D1CFC18-AB5A-4610-AC89-A1A1970251B1Q48956853-85D57FAD-97D7-48D1-8B71-F472AC4B6D47Q50294957-C0C781D8-FCF9-49FA-AD90-A32B8C2EA5A0Q52145798-331EBDE6-0A8C-45B9-A96A-DC2B0F904B87
P2860
Structure of aspartoacylase, the brain enzyme impaired in Canavan disease
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Structure of aspartoacylase, the brain enzyme impaired in Canavan disease
@ast
Structure of aspartoacylase, the brain enzyme impaired in Canavan disease
@en
Structure of aspartoacylase, the brain enzyme impaired in Canavan disease
@nl
type
label
Structure of aspartoacylase, the brain enzyme impaired in Canavan disease
@ast
Structure of aspartoacylase, the brain enzyme impaired in Canavan disease
@en
Structure of aspartoacylase, the brain enzyme impaired in Canavan disease
@nl
prefLabel
Structure of aspartoacylase, the brain enzyme impaired in Canavan disease
@ast
Structure of aspartoacylase, the brain enzyme impaired in Canavan disease
@en
Structure of aspartoacylase, the brain enzyme impaired in Canavan disease
@nl
P2093
P2860
P921
P356
P1476
Structure of aspartoacylase, the brain enzyme impaired in Canavan disease
@en
P2093
Craig A Bingman
Gary E Wesenberg
George N Phillips
Jason G McCoy
P2860
P304
P356
10.1073/PNAS.0607817104
P407
P50
P577
2007-01-09T00:00:00Z